2013 Year in Review: CDRH Promotion and Marketing Enforcement Letters


In 2013, FDA’s Center for Devices and Radiological Health (CDRH) made publicly available on its website a total of 22 promotion and marketing-related enforcement letters to device manufacturers. Of the 22 enforcement letters, 21 were Warning Letters. Although FDA stated publicly that it would begin publishing (for the first time) Untitled Letters on its website, FDA made publicly available only one Untitled Letter in 2013.

The vast majority of the 2013 enforcement letters resulted from CDRH review of company or product websites. However, 5 of the 22 letters cited materials reviewed by FDA during a manufacturing facility inspection. All five of those inspection-based letters were issued to foreign manufacturers in either China, South Korea or India.

Please see full alert below for more information.

LOADING PDF: If there are any problems, click here to download the file.

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© King & Spalding | Attorney Advertising

Written by:


King & Spalding on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.